Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2021-01-12 Investor Presentation
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed presentation made by Lupin Limited at the J.P. Morgan Healthcare Conference on January 12, 2021. It includes forward-looking statements, company performance highlights, strategic vision, product pipeline, and market positioning. The text explicitly mentions it is a presentation to be made at a conference, and the content is consistent with investor presentations focusing on financials, strategy, and market position. There is no indication that this is an official report like an Annual Report or Interim Report, nor is it a regulatory filing or announcement. The document length (15,000 characters) and detailed content support classification as an Investor Presentation rather than a brief announcement or certification.
2021-01-12 English
Presentation to be made at the J. P. Morgan Healthcare Conference.
Regulatory Filings
2021-01-12 English
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2021 ,inter alia, to consider and approve unaudited financial results for the ....
Regulatory Filings
2021-01-12 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-01-12 English
The Company will be participating in the J P Morgan Global Healthcare Conference to be held on Tuesday, January 12, 2021.
Regulatory Filings
2021-01-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (126 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-01-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.